ZeOmega Integrating McKesson InterQual Connect Into Jiva
Brings automated medical review and authorization connectivity to leading population health management solution, helping health plans expand automated authorization and move to exception-based UM
NEWTON, Mass.--(BUSINESS WIRE)--InterQual Connect™ is now being integrated with ZeOmega® Inc.’s Jiva™ population health management solution, McKesson announced today. ZeOmega is the first InterQual Alliance Partner to bring InterQual Connect’s cloud-based automated medical review and authorization capabilities to its health plan customers.
“Bringing InterQual Connect to Jiva means ZeOmega’s customers can streamline their workflow with the integrated medical review and enhanced automated authorization. Making utilization management (UM) more efficient is crucial for a world increasingly moving to value-based care.”
Now health plans and ACOs that use Jiva can expand automated authorization to include requests requiring a medical review, without leaving their Jiva system. They can use InterQual Connect’s secure connectivity to receive the InterQual medical review along with the authorization request from network providers and, in most cases, automatically return the authorization determination without manual intervention. By eliminating duplicative reviews and manual work, health plans can reduce administrative costs and speed authorizations while ensuring appropriate care.
“Prior authorization can be a costly burden for payers and providers alike, and can slow care delivery,” said Nilo Mehrabian, vice president of product management, Decision Management, at McKesson Health Solutions. “Bringing InterQual Connect to Jiva means ZeOmega’s customers can streamline their workflow with the integrated medical review and enhanced automated authorization. Making utilization management (UM) more efficient is crucial for a world increasingly moving to value-based care.”
InterQual Connect is part of the InterQual product line, McKesson's flagship decision support solution. InterQual Criteria help payers and providers ensure appropriate care across the medical and behavioral health continuums of care, which helps improve quality and reduce unnecessary cost. The InterQual clinical development team synthesizes the current, best evidence into a fully referenced decision support tool that is reviewed and updated annually. InterQual's development process, honed over nearly 40 years, is founded on rigorous review of the literature, and includes extensive peer review by practicing clinical experts across the United States.
For more information on McKesson Health Solutions, please visit our website, hear from our experts at MHSdialogue, follow us on Twitter, Like us on Facebook, or network with us on LinkedIn.
Related McKesson Health Solutions News
InterQual
2016 Evolves Utilization Management for a Value-Based World
McKesson
InterQual Connect Creates Connected Ecosystem for Medical Review and
Authorization
Nearly
500 Organizations License InterQual in Six-Month Period
About McKesson Corporation
McKesson Corporation, currently
ranked 11th on the FORTUNE 500, is a healthcare services and
information technology company dedicated to making the business of
healthcare run better. We partner with payers, hospitals, physician
offices, pharmacies, pharmaceutical companies and others across the
spectrum of care to build healthier organizations that deliver better
care to patients in every setting. McKesson helps its customers improve
their financial, operational and clinical performance with solutions
that include pharmaceutical and medical-surgical supply management,
healthcare information technology and business and clinical services.
For more information, visit us at www.mckesson.com.